CABALETTA BIO, INC. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/be54ea0f-1473-47b4-a5ee-bbfeba0035b6/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-172.2M | 2025-01-01 – 2025-12-31 | evidence 0001759138-26-000011 |
| FY 2024 | $-125.1M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-047201 |
| FY 2023 | $-74.7M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-034422 |
| FY 2022 | $-54.1M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-008298 |
| FY 2021 | $-46.3M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-010726 |
| FY 2020 | $-33.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013329 |
| FY 2019 | $-18.7M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-013929 |
| FY 2018 | $-6.2M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-013929 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).